Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Goldsmith

Showing results (571-580 of 665) with videos related to

Pageof 67
Sort By:
The Journal of Experimental Medicine|November 21, 2001
HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cellsD A Eckstein, M P Sherman, M L Penn, et al.
Experimental Dermatology|October 28, 1999
How realistic is cutaneous gene therapy?U R Hengge, L B Taichman, P Kaur, et al.
Journal of Virology|December 10, 1999
Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 diseaseB Schramm, M L Penn, R F Speck, et al.
Experimental Dermatology|February 25, 2000
Hot spot mutations in keratin 2e suggest a correlation between genotype and phenotype in patients with ichthyosis bullosa of SiemensY Suga, M J Arin, G Scott, et al.
The Journal of Arthroplasty|August 15, 2001
Comparative study of the activity of total hip arthroplasty patients and normal subjectsA A Goldsmith, D Dowson, B M Wroblewski, et al.
Journal of Virology|June 17, 1998
Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infectionR F Speck, M L Penn, J Wimmer, et al.
Journal of the American Academy of Dermatology|November 1, 1996
Full proceedings from the National Conference to Develop a National Skin Cancer Agenda. American Academy of Dermatology and Centers for Disease Control and Prevention, Washington, D.C., April 8-10, 1995L A Goldsmith, H K Koh, B A Bewerse, et al.
Journal of Virology|August 17, 2001
Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease statusJ F Kreisberg, D Kwa, B Schramm, et al.
Journal of Virology|May 9, 2000
Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissueJ C Grivel, M L Penn, D A Eckstein, et al.
Journal of Intellectual Disability Research : JIDR|May 2, 2023
Development and initial psychometric properties of the Warwick-Edinburgh Mental Wellbeing Scale-Intellectual Disability versionK Scior, M Patel, A Goldsmith-Sumner, et al.
Pageof 67

Showing results (571-580 of 665) with videos related to

Sort By:
Pageof 67
The Journal of Experimental Medicine|November 21, 2001
HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cellsD A Eckstein, M P Sherman, M L Penn, et al.
Experimental Dermatology|October 28, 1999
How realistic is cutaneous gene therapy?U R Hengge, L B Taichman, P Kaur, et al.
Journal of Virology|December 10, 1999
Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 diseaseB Schramm, M L Penn, R F Speck, et al.
Experimental Dermatology|February 25, 2000
Hot spot mutations in keratin 2e suggest a correlation between genotype and phenotype in patients with ichthyosis bullosa of SiemensY Suga, M J Arin, G Scott, et al.
The Journal of Arthroplasty|August 15, 2001
Comparative study of the activity of total hip arthroplasty patients and normal subjectsA A Goldsmith, D Dowson, B M Wroblewski, et al.
Journal of Virology|June 17, 1998
Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infectionR F Speck, M L Penn, J Wimmer, et al.
Journal of the American Academy of Dermatology|November 1, 1996
Full proceedings from the National Conference to Develop a National Skin Cancer Agenda. American Academy of Dermatology and Centers for Disease Control and Prevention, Washington, D.C., April 8-10, 1995L A Goldsmith, H K Koh, B A Bewerse, et al.
Journal of Virology|August 17, 2001
Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease statusJ F Kreisberg, D Kwa, B Schramm, et al.
Journal of Virology|May 9, 2000
Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissueJ C Grivel, M L Penn, D A Eckstein, et al.
Journal of Intellectual Disability Research : JIDR|May 2, 2023
Development and initial psychometric properties of the Warwick-Edinburgh Mental Wellbeing Scale-Intellectual Disability versionK Scior, M Patel, A Goldsmith-Sumner, et al.
Pageof 67